365 related articles for article (PubMed ID: 25814621)
1. Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy.
Hu W; Wang R; Li J; Zhang J; Wang W
Ann Clin Biochem; 2016 Jan; 53(Pt 1):67-74. PubMed ID: 25814621
[TBL] [Abstract][Full Text] [Related]
2. Association of irisin and FNDC5 rs16835198 G>T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study.
Khidr EG; Ali SS; Elshafey MM; Fawzy OA
Gene; 2017 Aug; 626():26-31. PubMed ID: 28479383
[TBL] [Abstract][Full Text] [Related]
3. Serum Irisin and Diabetic Nephropathy in Patients with Diabetes Mellitus.
Kawada T
Horm Metab Res; 2021 Dec; 53(12):825. PubMed ID: 34891213
[TBL] [Abstract][Full Text] [Related]
4. Irisin modulates the association of interleukin-17A with the presence of non-proliferative diabetic retinopathy in patients with type 2 diabetes.
Wang C; Wang L; Liu J; Song J; Sun Y; Lin P; Liang K; Liu F; He T; Sun Z; Hou X; Chen L
Endocrine; 2016 Aug; 53(2):459-64. PubMed ID: 26940815
[TBL] [Abstract][Full Text] [Related]
5. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy.
Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M
Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825
[TBL] [Abstract][Full Text] [Related]
6. The association of serum and vitreous adropin concentrations with diabetic retinopathy.
Li S; Sun J; Hu W; Liu Y; Lin D; Duan H; Liu F
Ann Clin Biochem; 2019 Mar; 56(2):253-258. PubMed ID: 30514096
[TBL] [Abstract][Full Text] [Related]
7. Association Between Serum Irisin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.
Wang R; Liu H
Horm Metab Res; 2021 May; 53(5):293-300. PubMed ID: 33962476
[TBL] [Abstract][Full Text] [Related]
8. Lower circulating irisin is associated with type 2 diabetes mellitus.
Liu JJ; Wong MD; Toy WC; Tan CS; Liu S; Ng XW; Tavintharan S; Sum CF; Lim SC
J Diabetes Complications; 2013; 27(4):365-9. PubMed ID: 23619195
[TBL] [Abstract][Full Text] [Related]
9. High plasma prorenin in diabetes mellitus and its correlation with some complications.
Franken AA; Derkx FH; Man in't Veld AJ; Hop WC; van Rens GH; Peperkamp E; de Jong PT; Schalekamp MA
J Clin Endocrinol Metab; 1990 Oct; 71(4):1008-15. PubMed ID: 2205621
[TBL] [Abstract][Full Text] [Related]
10. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
Kato K; Osawa H; Ochi M; Kusunoki Y; Ebisui O; Ohno K; Ohashi J; Shimizu I; Fujii Y; Tanimoto M; Makino H
Clin Endocrinol (Oxf); 2008 Mar; 68(3):442-9. PubMed ID: 17970779
[TBL] [Abstract][Full Text] [Related]
11. Serum and Vitreous Pentraxin 3 Concentrations in Patients with Diabetic Retinopathy.
Zhou W; Hu W
Genet Test Mol Biomarkers; 2016 Mar; 20(3):149-53. PubMed ID: 26836044
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
13. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
[TBL] [Abstract][Full Text] [Related]
14. Association of Irisin Circulating Level with Diabetic Retinopathy: A Case-Control Study.
Tarboush NA; Abu-Yaghi NE; Al Ejeilat LH; Wahed RKA; Jeris IN
Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):36-42. PubMed ID: 30223289
[TBL] [Abstract][Full Text] [Related]
15. Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.
Tian M; Wang J; Wei Y; Lu Q; Huang B
J Investig Med; 2016 Oct; 64(7):1209-12. PubMed ID: 27422995
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery.
Ebert T; Stepan H; Schrey S; Kralisch S; Hindricks J; Hopf L; Platz M; Lossner U; Jessnitzer B; Drewlo S; Blüher M; Stumvoll M; Fasshauer M
Cytokine; 2014 Feb; 65(2):153-8. PubMed ID: 24355429
[TBL] [Abstract][Full Text] [Related]
17. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
García-Fontana B; Reyes-García R; Morales-Santana S; Ávila-Rubio V; Muñoz-Garach A; Rozas-Moreno P; Muñoz-Torres M
Endocrine; 2016 Apr; 52(1):54-62. PubMed ID: 26438394
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.
Looker HC; Fagot-Campagna A; Gunter EW; Pfeiffer CM; Narayan KM; Knowler WC; Hanson RL
Diabetologia; 2003 Jun; 46(6):766-72. PubMed ID: 12774164
[TBL] [Abstract][Full Text] [Related]
19. Nephropathy, but not Angiographically Proven Retinopathy, is Associated with Neutrophil to Lymphocyte Ratio in Patients with Type 2 Diabetes.
Ciray H; Aksoy AH; Ulu N; Cizmecioglu A; Gaipov A; Solak Y
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):267-71. PubMed ID: 25853704
[TBL] [Abstract][Full Text] [Related]
20. Association of serum pentraxin 3 concentrations with diabetic nephropathy.
Wang R; Zhang J; Hu W
J Investig Med; 2016 Aug; 64(6):1124-7. PubMed ID: 27233528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
